WOONSOCKET – CVS Caremark Corp. is taking incoming fire from new sources: lawmakers in Washington, D.C., and Topeka, Kan.
The House Subcommittee on Federal Workforce, Postal Service and the District of Columbia voted last week to bar CVS from bidding to renew its contract to provide federal workers with prescription drugs.
Seifert Systems Invests in Energy Efficiency to Strengthen Operations
For manufacturers, energy is more than just another operating expense. It plays a critical role…
Learn More
The federal contract, valued at about $10 billion and providing coverage to 8 million employees, is one of CVS Caremark’s largest, according to Bloomberg News.
The subcommittee passed a bill sponsored by U.S. Rep. Stephen Lynch, D-Mass., that would prevent pharmacy-benefit management (PBM) companies which also own retail stores from bidding on the contract. The bill now moves on to the House Committee on Oversight and Government Reform.
Separately, state lawmakers in Kansas will hold a hearing in Topkea on Monday to examine allegations that CVS is overcharging government employees there for generic drugs, The Topeka Capital-Journal reported.
The union-backed pressure group Change to Win, which is waging a campaign against CVS, helped draw attention to the issue. CVS’ contract to provide PBM services to Kansas’ 100,000 government workers expires at the end of the year.
Additional information is available at cvscaremark.com.
